Corcept terminates Phase III pancreatic ductal adenocarcinoma trial
Apart from pancreatic ductal adenocarcinoma, studies in liver disease, venous leg ulcer, sleep apnoea, and ocular issues are also reviewed.
Stay updated with breaking news from Drug Processing Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Apart from pancreatic ductal adenocarcinoma, studies in liver disease, venous leg ulcer, sleep apnoea, and ocular issues are also reviewed.
Cerevance CMO Jordan Dubow shares exclusive details on the first of two planned registrational trials in Parkinson’s disease.
There are 100–400 million Dengue fever infections each year, and cases are quickly rising. How can manufacturers develop reliable antivirals and vaccines?
After Biogen all but waved the white flag on its once-promising Aduhelm, Clinical Trials Arena explores how drug developers can dodge a similar fate.
Transcenta has dosed the first subject in the Phase I trial of its drug candidate, TST002 (Blosozumab), to treat osteoporosis in China.